National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 63030 [2021-24771]
Download as PDF
<![CDATA[
63030
Federal Register / Vol. 86, No. 217 / Monday, November 15, 2021 / Notices
Liberty Street, New York, New York
10045–0001. Comments can also be sent
electronically to
Comments.applications@ny.frb.org:
1. Valley National Bancorp, New
York, New York; to acquire Bank Leumi
Le-Israel Corporation, and thereby
indirectly acquire Bank Leumi USA,
both of New York, New York.
B. Federal Reserve Bank of Atlanta
(Erien O. Terry, Assistant Vice
President) 1000 Peachtree Street NE,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. Business First Bancshares, Inc.,
Baton Rouge, Louisiana; to merge with
Texas Citizens Bancorp, Inc., and
thereby indirectly acquire Texas
Citizens Bank, N.A., both of Pasadena,
Texas.
C. Federal Reserve Bank of
Minneapolis (Chris P. Wangen,
Assistant Vice President), 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291. Comments can also be sent
electronically to MA@mpls.frb.org:
1. First Interstate BancSystem, Inc.,
Billings, Montana; to merge with Great
Western Bancorp, Inc., and thereby
indirectly acquire Great Western Bank,
both of Sioux Falls, South Dakota.
Board of Governors of the Federal Reserve
System, November 9, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–24875 Filed 11–12–21; 8:45 am]
BILLING CODE P
FEDERAL RESERVE SYSTEM
khammond on DSKJM1Z7X2PROD with NOTICES
Jkt 256001
Board of Governors of the Federal Reserve
System, November 9, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
National Institutes of Health
[FR Doc. 2021–24876 Filed 11–12–21; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIEHS.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
National Institute of Environmental
Health Sciences, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
16:42 Nov 12, 2021
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Centers for Research on
Structural Biology of Infectious Diseases
(N01).
Date: December 14, 2021.
Time: 10:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F30A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Ellen S. Buczko, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F30A, Rockville, MD
20852, (240) 669–5028, ebuczko1@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
BILLING CODE P
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
VerDate Sep<11>2014
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than November 30, 2021.
A. Federal Reserve Bank of
Minneapolis (Chris P. Wangen,
Assistant Vice President), 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291. Comments can also be sent
electronically to MA@mpls.frb.org:
1. Bosshard Bank Irrevocable Trust u/
a/d October 21, 2021, South Dakota
Trust Company, LLC., as trustee, both of
Sioux Falls, South Dakota; and Andrew
R. Bosshard, as trust protector, La
Crosse, Wisconsin; to join the Bosshard
Family Group, a group acting in concert,
to acquire voting shares of Bosshard
Banco, Ltd., La Crosse, Wisconsin, and
thereby indirectly acquire voting shares
of Intercity State Bank, Schofield,
Wisconsin, and The First National Bank
of Bangor, Bangor, Wisconsin; and
acquire voting shares of Clayton
Bankshares, Inc., and thereby indirectly
acquire voting shares of Citizens State
Bank-La Crosse, both of La Crosse,
Wisconsin.
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Dated: November 8, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–24771 Filed 11–12–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Environmental
Health Sciences; Notice of Meeting
E:\FR\FM\15NON1.SGM
15NON1
]]>Agencies
[Federal Register Volume 86, Number 217 (Monday, November 15, 2021)]
[Notices]
[Page 63030]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24771]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Centers for Research on Structural
Biology of Infectious Diseases (N01).
Date: December 14, 2021.
Time: 10:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F30A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Ellen S. Buczko, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F30A,
Rockville, MD 20852, (240) 669-5028, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 8, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-24771 Filed 11-12-21; 8:45 am]
BILLING CODE 4140-01-P
